NATCAPSUQBSENatural Capsules LtdHighNeutral
Announced Wed, 27 May · 19:45 IST

Approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. Approved the re-appointment of Mr. Shri Laxminarayana Moondra ....

Pat Growth 25pctEbitda Margin ExpansionRelated Party TransactionsResults View source PDF

NATCAPSUQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.1%1-day move
₹169.99
prior close
₹160.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.7+2.5+2.5+1.5-7.1-7.8-7.1-8.6-7.3-8.2-5.3-10.4
Up moveDown movePending
AI summary

Natural Capsules Limited reported strong FY2026 results with standalone revenue of Rs 17,377 lakhs (up 3.5% YoY) and net profit of Rs 1,121 lakhs (up 67% YoY). Consolidated revenue stood at Rs 18,720 lakhs with net profit of Rs 1,707 lakhs (up 37% YoY). The Board approved re-appointment of Whole-time Director Mr. Laxminarayan Moondra for 3 years, appointed M/s. Mallya & Mallya as Internal Auditor and Mr. Akshay Dutta as Company Secretary. The company allotted 25,000 equity shares upon ESOP exercise, increasing paid-up capital to Rs 10.41 crore. Statutory auditors P. Chandrasekar LLP issued an unmodified (clean) opinion. One manufacturing unit had temporary shutdown from December 26 due to regulatory issues but resumed from January 30, 2026.

Likely market impact

Strong profit growth exceeding 25% signals operational efficiency gains. The clean audit opinion removes key risks for investors. Share capital dilution from ESOP exercise is minimal at 0.24%. Overall, positive development for shareholders with robust bottom-line growth.